QTTB (q32bio.com) Sof foyda

QTTB (q32bio.com) - kompaniyaning tovar belgisi

Q32 Bio Inc. (QTTB) o'z strategiyasini ADX-097 sinovlariga tayangan holda, komplement patologiyalariga qarshi kurashish uchun antitanalarni ishlab chiqishga asoslaydi. Kirish to'siqlari uzoq muddatli tadqiqotlar va qat'iy patent nazorati bilan belgilanadi. Ventur potentsiali sanoat gigantlari bilan tuzilgan ittifoqlar orqali kuchaytirilgan. Kompaniyaning sof foyda ko'rsatkichi ushbu tendentsiyalarni vizuallashtiradi, bunda 0.03 qiymati joriy moliyaviy dinamikaning bazaviy ko'rsatkichi bo'lib xizmat qiladi.

QTTB (Q32 Bio Inc.) Sof foyda tarixi 27.03.2024dan 29.10.2026gacha

q32bio.com (QTTB) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Q32 Bio|QTTB - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Q32 Bio Inc.|QTTB - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Q32 Bio|QTTB - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi q32bio.com|QTTB - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Q32 Bio Inc.|QTTB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Q32 Bio|QTTB - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Q32 Bio Inc.|QTTB - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Q32 Bio|Shoshilinch likvidlik q32bio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
QTTB - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Q32 Bio Inc.
Q32 Bio Inc asosiy tovari

Klinik sinovlar bosqichida bo'lgan va hali daromadga chiqmagan Q32 Bio Inc. kompaniyasi uchun ushbu ko'rsatkich barcha daromadlar va umumiy xarajatlar orasidagi farq orqali naqd pulning sarflanish darajasini aks ettiradi. Kompaniyaning yalpi foydasini tahlil qilish tibbiy ishlanmalar xarajatlari ortib borayotgan sharoitda emitentning moliyaviy barqarorligini baholash imkonini beradi, bu esa ushbu grafikni operatsion samaradorlik detektori va investitsiya risklarini nazorat qilishning asosiy vositasiga aylantiradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN - Kompaniyaning sof foydasi|Yillik sof foyda Pharming Corp (PHAR)|NKTR (Nektar Therapeutics) - Sof daromad|UPB (upstreambio.com) - Kompaniyaning sof foydasi|Sof daromad ZBIO|IMNM: Yakuniy foyda|Sof foyda GOSS|Kompaniyaning sof foydasi KALV (KalVista Corp)|Sof foyda SEPN (Septerna Inc)|Sof moliyaviy natija pieris.com (PVLA)|SVRA - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Rigel Pharma|ANAB (AnaptysBio Corp) - Sof daromad|Astria Corp - Yakuniy foyda|ENGN (enGene Holdings Inc.) - Sof foyda|rapt.com (RAPT) - Sof moliyaviy natija|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|Aclaris Therapeutics Inc. - Kompaniya foydasi|Sof foyda KYTX (Kyverna)|TLSA - Sof daromad|CABA: Sof daromad|Sof moliyaviy natija ventyxbio.com VTYX|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Yillik sof foyda Avalo Therapeutics, Inc. AVTX|Sof daromad ELDN|AGEN (Agenus, Inc) - Soliqlar to‘langandan keyingi foyda|Sof daromad CLYM (Climb Bio Inc)|Soliqlar to‘langandan keyingi foyda ZURA|Sof foyda ATYR (aTyr Pharma)|Adagene Inc - Kompaniyaning sof foydasi|IMA - Kompaniyaning sof foydasi|Soliqdan keyingi foyda STTK|EQ: Sof foyda|Connect Biopharma Holdings Limited - Yakuniy foyda|IMUX (Immunic Therapeutics) - Sof foyda|Sof foyda Atara Biotherapeutics Inc|Kompaniyaning sof foydasi InflaRx N.V. (IFRX)|XFOR (X4 Pharmaceuticals, Inc) - Yakuniy foyda|Kompaniyaning sof foydasi Adicet Bio, Inc. ACET|CELU - Sof daromad|INmune Bio - Sof foyda|BRNS - Sof foyda|KZR (Kezar Life Sciences, Inc) - Sof daromad|SAB Biotherapeutics Inc - Yakuniy foyda|AKTX (Akari Therapeutics) - Sof foyda|Enlivex Therapeutics, Ltd. (ENLV) - Sof moliyaviy natija|Kompaniyaning sof foydasi GeoVax (GOVX)|Sof daromad Edesa Biotech Inc EDSA|Kompaniyaning sof foydasi iBio Corp IBIO|CARM - Sof daromad|XTLB: Sof daromad|BOLT - Sof foyda|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Kompaniya foydasi APVO|AIM (AIM ImmunoTech) - Sof foyda|Kompaniyaning sof daromadi Aditxt Corp ADTX|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|xortx.com (XRTX) - Yillik sof foyda|Vyome Holdings - Sof daromad|Revelation Biosciences Inc - Kompaniyaning sof foydasi|INDP: Sof daromad|Yakuniy foyda SCNI (BiondVax Pharmaceuticals)|CALI: Sof foyda|AFMD (Affimed N.V.) - Kompaniyaning sof foydasi|ALLK (Allakos Inc) - Sof foyda|HOOKIPA (HOOK) - Sof moliyaviy natija|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|ITOS - Kompaniyaning sof daromadi|Ocean Biomedical, Inc. - Sof daromad|Yakuniy foyda TCBP|Third Harmonic Bio, Inc. - Sof foyda